Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Author Correction: A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing

    Allegra A. Petti, Stephen R. Williams, Christopher A. Miller in Nature Communications (2022)

  2. Article

    Open Access

    Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells

    Recurrent mutations in IDH1 or IDH2 in acute myeloid leukemia (AML) are associated with increased DNA methylation, but the genome-wide patterns of this hypermethylation phenotype have not been comprehensively stu...

    Elisabeth R. Wilson, Nichole M. Helton, Sharon E. Heath, Robert S. Fulton in Leukemia (2022)

  3. Article

    Open Access

    Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome

    Germline pathogenic variants in DNMT3A were recently described in patients with overgrowth, obesity, behavioral, and learning difficulties (DNMT3A Overgrowth Syndrome/DOS). Somatic mutations in the DNMT3A gene ar...

    Amanda M. Smith, Taylor A. LaValle, Marwan Shinawi in Nature Communications (2021)

  4. Article

    Open Access

    Co-evolution of tumor and immune cells during progression of multiple myeloma

    Multiple myeloma (MM) is characterized by the uncontrolled proliferation of plasma cells. Despite recent treatment advances, it is still incurable as disease progression is not fully understood. To investigate...

    Ruiyang Liu, Qingsong Gao, Steven M. Foltz, Jared S. Fowles in Nature Communications (2021)

  5. Article

    Open Access

    Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression

    Colorectal cancer (CRC) is the most common gastrointestinal malignancy in the U.S.A. and approximately 50% of patients develop metastatic disease (mCRC). Despite our understanding of long non-coding RNAs (lncR...

    Jessica M. Silva-Fisher, Ha X. Dang, Nicole M. White in Nature Communications (2020)

  6. Article

    Open Access

    A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing

    Virtually all tumors are genetically heterogeneous, containing mutationally-defined subclonal cell populations that often have distinct phenotypes. Single-cell RNA-sequencing has revealed that a variety of tum...

    Allegra A. Petti, Stephen R. Williams, Christopher A. Miller in Nature Communications (2019)

  7. Article

    Open Access

    DNMT3AR882-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3AR882C OCI-AML3 leukemia cell line

    David Chen, Matthew Christopher, Nichole M. Helton, Ian Ferguson in Blood Cancer Journal (2018)

  8. Article

    Open Access

    Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential

    Hematopoietic clones harboring specific mutations may expand over time. However, it remains unclear how different cellular stressors influence this expansion. Here we characterize clonal hematopoiesis after tw...

    Terrence N. Wong, Christopher A. Miller, Matthew R. M. Jotte in Nature Communications (2018)

  9. Article

    Open Access

    Visualizing tumor evolution with the fishplot package for R

    Massively-parallel sequencing at depth is now enabling tumor heterogeneity and evolution to be characterized in unprecedented detail. Tracking these changes in clonal architecture often provides insight into t...

    Christopher A. Miller, Joshua McMichael, Ha X. Dang, Christopher A. Maher in BMC Genomics (2016)

  10. Article

    Open Access

    Patterns and functional implications of rare germline variants across 12 cancer types

    Large-scale cancer sequencing data enable discovery of rare germline cancer susceptibility variants. Here we systematically analyse 4,034 cases from The Cancer Genome Atlas cancer cases representing 12 cancer ...

    Charles Lu, Mingchao **e, Michael C. Wendl, Jiayin Wang in Nature Communications (2015)

  11. No Access

    Article

    Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

    Somatic TP53 mutations are highly prevalent in therapy-related acute myeloid leukaemia and myelodysplastic syndrome, which arise as complications of cytotoxic chemotherapy or radiotherapy; although it was believe...

    Terrence N. Wong, Giridharan Ramsingh, Andrew L. Young, Christopher A. Miller in Nature (2015)

  12. No Access

    Article

    Age-related mutations associated with clonal hematopoietic expansion and malignancies

    Systematic analysis of cancer-associated mutations in the blood cells of healthy individuals.

    Mingchao **e, Charles Lu, Jiayin Wang, Michael D McLellan in Nature Medicine (2014)

  13. No Access

    Article

    DGIdb: mining the druggable genome

    A database of known drug-gene interactions, with information derived from many public sources, allows the identification of genes that are currently targeted by a drug and the membership of genes in a category...

    Malachi Griffith, Obi L Griffith, Adam C Coffman, James V Weible in Nature Methods (2013)

  14. Article

    Open Access

    Mutational landscape and significance across 12 major cancer types

    The Cancer Genome Atlas (TCGA) has used the latest sequencing and analysis methods to identify somatic variants across thousands of tumours. Here we present data and analytical results for point mutations and ...

    Cyriac Kandoth, Michael D. McLellan, Fabio Vandin, Kai Ye, Beifang Niu in Nature (2013)

  15. Article

    Open Access

    BreakTrans: uncovering the genomic architecture of gene fusions

    Producing gene fusions through genomic structural rearrangements is a major mechanism for tumor evolution. Therefore, accurately detecting gene fusions and the originating rearrangements is of great importance...

    Ken Chen, Nicholas E Navin, Yong Wang, Heather K Schmidt, John W Wallis in Genome Biology (2013)

  16. Article

    Erratum: The Pediatric Cancer Genome Project

    Nat. Genet. 44, 619–622 (2012); published online 29 May 2012; corrected after print 9 July 2012 In the version of this article initially published, there were errors in the labeling of Figure 1b. Specifically,...

    James R Downing, Richard K Wilson, **ghui Zhang, Elaine R Mardis in Nature Genetics (2012)

  17. No Access

    Article

    The Pediatric Cancer Genome Project

    James R Downing, Richard K Wilson, **ghui Zhang, Elaine R Mardis in Nature Genetics (2012)

  18. Article

    Open Access

    Whole-genome analysis informs breast cancer response to aromatase inhibition

    To correlate the variable clinical features of oestrogen-receptor-positive breast cancer with somatic alterations, we studied pretreatment tumour biopsies accrued from patients in two studies of neoadjuvant ar...

    Matthew J. Ellis, Li Ding, Dong Shen, **gqin Luo, Vera J. Suman, John W. Wallis in Nature (2012)

  19. Article

    Open Access

    Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

    The sequencing of AML genomes of eight patients before and after relapse reveals two major patterns of clonal evolution, with chemotherapy appearing to have a role in both patterns.

    Li Ding, Timothy J. Ley, David E. Larson, Christopher A. Miller in Nature (2012)

  20. No Access

    Article

    Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

    Matthew Walter and colleagues report the whole-genome sequencing of a secondary acute myeloid leukemia sample and a matched normal tissue sample. Further analysis of additional subjects identified recurrent mu...

    Timothy A Graubert, Dong Shen, Li Ding, Theresa Okeyo-Owuor, Cara L Lunn in Nature Genetics (2012)

previous disabled Page of 2